Myomo Makes NYSE American Section 610(b) Public Announcement
March 15 2023 - 8:30AM
Business Wire
Myomo, Inc. (NYSE American: MYO) ("Myomo" or the
"Company"), a wearable medical robotics company that offers
increased functionality for those suffering from neurological
disorders and upper-limb paralysis, today announced that, as
previously disclosed in its Annual Report on Form 10-K for the year
ended December 31, 2022 filed on March 13, 2023 with the Securities
and Exchange Commission, the audited financial statements for the
year ended December 31, 2022 included in the 10-K contained an
audit opinion from its independent registered public accounting
firm, which included a going concern emphasis of matter
paragraph.
This announcement is made pursuant to NYSE American Company
Guide Section 610(b), which requires separate public announcement
of the receipt of an audit opinion containing a going concern
paragraph. This announcement does not represent any change or
amendment to the Company’s consolidated financial statements or to
its Annual Report on Form 10-K for the year ended December 31,
2022.
About Myomo
Myomo, Inc. is a wearable medical robotics company that offers
improved arm and hand function for those suffering from
neurological disorders and upper-limb paralysis. Myomo develops and
markets the MyoPro product line. MyoPro is a powered upper-limb
orthosis designed to support the arm and restore function to the
weakened or paralyzed arms of certain patients suffering from CVA
stroke, brachial plexus injury, traumatic brain or spinal cord
injury, ALS or other neuromuscular disease or injury. It is
currently the only marketed device that, sensing a patient’s own
EMG signals through non-invasive sensors on the arm, can restore an
individual’s ability to perform activities of daily living,
including feeding themselves, carrying objects and doing household
tasks. Many are able to return to work, live independently and
reduce their cost of care. Myomo is headquartered in Boston,
Massachusetts, with sales and clinical professionals across the
U.S. and representatives internationally. For more information,
please visit www.myomo.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230315005511/en/
For Myomo: ir@myomo.com Investor Relations: Kim
Sutton Golodetz LHA Investor Relations 212-838-3777
kgolodetz@lhai.com
Myomo (AMEX:MYO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Myomo (AMEX:MYO)
Historical Stock Chart
From Apr 2023 to Apr 2024